Clinical Trial Update: Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)

View source ↗

Summary

A completed clinical trial investigating adherence to Tenofovir Alafenamide (TAF) in people with HIV/AIDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: HIV/AIDS, Adherence, Medication | Status: COMPLETED